Group Golf Remedy artwork sequence raises cash for psychological well being

Group golf therapy is a team of developers dedicated to uncovering the link between golf and mental health.

The founders of GGT are former college golfers, Bradford Wilson, Connor Laubenstein and Drew Westphal. Each of them are on individual journeys to redefine their relationship with the game and have deeper golf conversations.

Group Golf Therapy has partnered with three artists to raise funds for various mental health organizations. You named this art series Mind Your Golf. Every piece is abstract, playful and all wins come from that National Queer & Trans Therapists of Color Network, that Boris Lawrence Henson Foundation, and Courage Milwaukee. Each piece is priced at $ 36.

GGT Mind Your Golf by Tony Knapton. (Tony Knapton)

GGT Mind Your Golf by Luke Schaffner. (Lukas Schaffner)

the Group golf therapy podcast is available on Spotify, Apple Podcasts, Google Podcasts, Stitcher, and Podbean. You will have great discussions with current and former professional golfers, golf industry professionals, golf enthusiasts and mental health experts.

Occasionally we recommend interesting products, services and play opportunities. When you make a purchase by clicking on any of the links we can earn an affiliate fee. However, Golfweek operates independently and this does not affect our reporting.

Type Remedy: Publish-pandemic work put on ought to be comfy but fashionable

Links to the breadcrumb trail

Author of the article:

Helene Oseen Janet Mezzarobba tries on power casual work clothes in Calgary at Sophie Grace’s. (Amelia top $ 140, Hamilton pants $ 195). Darren Makowichuk / Postmedia Photo by Darren Makowichuk /DARREN MAKOWICHUK / Postmedia

Reviews and recommendations are impartial and products are independently selected. Postmedia can earn affiliate commission from purchases made through links on this page.

Article content

During a seemingly endless pandemic, women have mixed emotions about the reality of getting back to the office. The thought of getting dressed again may make you feel a little excited, but it will be difficult to give up the comforts of doing my job at home.


This ad hasn’t loaded yet, but your article continues below.

Article content

PR professional Janet Mezzarobba stopped working in her office in March 2020. Now her workplace is making plans to bring people back. After so many months pairing Zoom-ready tops and trophy jewelry with sweatshirts or yoga pants, Janet wonders how she is going to survive a full day of work in her pre-pandemic outfits.

In the past 18 months, she has not worn what she considers to be an appropriate office look from head to toe. In the times when she could keep the camera off for conference calls, she did. Now she looks at the work clothes that are hanging in her closet and realizes that they are from another time. When she goes back to the office, the running shorts and oversized sweatshirts she wore won’t be enough. Again, every morning she will go to the trouble of choosing attractive clothes, styling her hair and putting on make-up.


This ad hasn’t loaded yet, but your article continues below.

Article content

Janet has always been a well-dressed woman. She consciously dresses for her day because she understands that her dress choices not only affect how people perceive her, but also how she feels about herself and her talents. Wearing clothes that make her feel classy and confident without fuss has always been her style. Now she’s looking for a work-friendly cloakroom overhaul designed for an energetic, active, athletic woman in leadership positions. When she thinks about getting dressed, she wants fabrics that are soft and comfortable with the fit and shine of workwear. She doesn’t want to wear things that are tight at the waist or sleeves and blazers that don’t allow much movement.

Janet Mezzarobba searches Sophie Grace ( for upscale leisure fashion for a return to professional life.  She paired her dress with a Violet Blazer ($ 250).  Darren Makowichuk / Postmedia Janet Mezzarobba searches Sophie Grace ( for upscale leisure fashion for a return to professional life. She paired her dress with a Violet Blazer ($ 250). Darren Makowichuk / Postmedia Photo by Darren Makowichuk /DARREN MAKOWICHUK / Postmedia

Power Casual is the new dress for success

Women returning to work won’t be sure what to wear as hybrid clothing evolves into a new dress code. The new rules of office attire become a big guessing game. New eras always herald new fashions. Although office attire trends have generally been in a more casual direction than yesterday’s classic attire, today’s new fashions are old fashions with a new twist. The focus is on fabrics that are thick and soft with stretch. A pleasantly smooth fabric that is crease-resistant and breathable is the epitome of casual luxury.


This ad hasn’t loaded yet, but your article continues below.

Article content

Fashion designers used to dictate style trends. Savvy brands today orient themselves towards women by listening to their wants and needs after the pandemic. They create pieces with a focus on comfort that offer practicality and functionality without compromising on style. Chances are that the new office wear will consist of stretchy pants, skirts, jackets, and comfortable clothes. Elastic cuffs will find their way into everything.

Coco Chanel’s maxim “Luxury must be comfortable, otherwise it is not luxury” applies.

Janet Mezzarobba models a navy Ashley dress ($ 210) and a Carl Abad, Fun Not Serious necklace at Sophie Grace.  Darren Makowichuk / Postmedia Janet Mezzarobba models a navy Ashley dress ($ 210) and a Carl Abad, Fun Not Serious necklace at Sophie Grace. Darren Makowichuk / Postmedia Photo by Darren Makowichuk /DARREN MAKOWICHUK / Postmedia

The tips from the experts

Q. Can I wear white after Labor Day?

A. Nobody is sure how this subjective rule of “don’t know after Labor Day” came about. Nobody should feel the need to follow her.


This ad hasn’t loaded yet, but your article continues below.

Article content

White can be worn all year round. The fabric is important, not the color. Perhaps at the end of summer, you might be packing up your breezy white clothes in favor of firmer fabrics that will keep you warm in the cooler days to come.

The French designer Coco Chanel (1883-1971) used natural white – a warm alternative to strong white – as the key color in her collections, which she wore all year round. White also reflects light and brightens the wearer’s face, so she uses pearls to embellish clothing, as well as creating beautiful brooches and fine jewelry.

Each color has a meaning and personality. From a psychological point of view, natural white means reducing stress. It has a calming effect and is comfortable to wear as it does not require physical energy to wear. We are naturally drawn to it and others are drawn to us when we wear it.

Continue. Wear white after Labor Day – it might be just what you need for a dose of fresh energy, optimism, and the joy of putting on again.

Helene Oseen has been a fashion author for many years and a sought-after stylist. She helps women find confidence and style while making friends with themselves and fashion. What’s your closet identity? Take the quiz and find out below

Share this article on your social network


This ad hasn’t loaded yet, but your article continues below.

By clicking the registration button, you agree to receive the above newsletter from Postmedia Network Inc. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300


Postmedia advocates a lively but civil discussion forum and encourages all readers to share their thoughts on our articles. It can take up to an hour for comments to be moderated before they appear on the site. We ask that you keep your comments relevant and respectful. We turned email notifications on – you will now receive an email when you’ve received a reply to your comment, there’s an update on a comment thread you’re following, or when a user you follow follows comments . Visit our Community guidelines for more information and details on customizing your E-mail the settings.

Biogen’s Alzheimer’s drug accepted by FDA, first new remedy in almost 20 years

The Food and Drug Administration approved on Monday BiogenicThe Alzheimer’s drug aducanumab is the first drug approved by the US authorities to slow cognitive decline in people with Alzheimer’s and the first new drug for the disease in almost two decades.

The FDA’s decision was eagerly awaited. The drug, which is marketed under the name Aduhelm, is also expected to generate billions in sales for the company offers new hope to friends and families of patients living with the disease.

“We are aware of the attention associated with this approval,” said Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, in a press release. “We know that Aduhelm has drawn the attention of the press, the Alzheimer’s patient community, our elected officials and other interested stakeholders.”

“With treatment for a serious, life-threatening disease in balance, it makes sense that so many people followed the outcome of this review,” added Cavazzoni.

The FDA said it would continue to monitor the drug when it hits the US market. The agency granted approval on the condition that Biogen conduct another clinical study.

Alzheimer’s disease is a progressive neurodegenerative disease that slowly destroys memory and thinking skills. More than 6 million Americans are reportedly living with it Alzheimer’s Association estimates. According to the group, this number is expected to rise to almost 13 million by 2050.

To date, there have been no FDA-approved drugs that can slow the mental decline of Alzheimer’s, the sixth leading cause of death in the United States. The agency has approved Alzheimer’s drugs that are aimed at relieving symptoms rather than slowing the disease itself down.

Federal agencies have come under intense pressure from friends and family members of Alzheimer’s patients to speed up aducanumab, but the road to regulatory approval has been controversial since it showed promise in 2016.

In March 2019, Biogen stopped work on the drug after analysis by an independent group found it was unlikely to work. The company then shocked investors a few months later by announcing that it would apply for regulatory approval for the drug after all.

Biogen’s shares rose in November after gaining support from FDA staff, who said the company had shown very “compelling” evidence of aducanumab’s effectiveness and that it had “an acceptable safety profile that would support its use in people with Alzheimer’s disease”.

But two days later, an external panel of experts advises the US authorities unexpectedly declined to support the experimental drug citing inconclusive data. It also criticized the agency’s staff for rating it too positively.

When Biogen filed for approval for the drug in late 2019, its scientists said a new analysis of a larger data set showed that aducanumab “reduces clinical decline in patients with early-stage Alzheimer’s disease.”

Alzheimer’s experts and Wall Street analysts were immediately skeptical, wondering whether the clinical trial data was enough to prove the drug works and whether approval could make it difficult for other companies to enroll patients in their own drug trials.

Some doctors said they won’t prescribe it the drug when it hits the market due to the mixed data package that supports the company’s application.

Supporters, including advocacy groups and family members of patients desperately looking for a new treatment, have admitted the data is not perfect. However, they argue that it could help some patients with Alzheimer’s, a progressive and debilitating disease.

Biogen’s drug targets a “sticky” compound in the brain known as beta-amyloid that scientists expect to play a role in the devastating disease. The company previously estimated that approximately 1.5 million people with early-stage Alzheimer’s in the United States could be candidates for the drug, according to Reuters.

The FDA’s decision is expected to reverberate across the biopharmaceutical sector, RBC Capital Markets analyst Brian Abrahams said in a June 1 announcement to customers.

The US agency said Monday that it had determined that there was “substantial evidence” that the drug was helping patients. “With Aduhelm approved by the FDA, an important and critical new treatment is available to patients with Alzheimer’s disease to combat the disease,” it said.

Prince Harry ‘volunteered’ to shoot remedy session | Leisure

Prince Harry “volunteered” to film an on-camera therapy session for “The Me You Can’t See”.

The 36-year-old King agreed to be filmed during a therapy session for the Apple TV + show, and Dawn Porter, who co-co-directed the series with Asif Kapadia, announced he was excited about his mental health journey.

Commenting on the docu series, Dawn said, “Asif Kapadia worked very closely with Harry and it was really interesting because we’d worked on the series for so long that we knew a lot about what Prince Harry was doing to keep his mind on wellness.

“And when you have Oprah Winfrey and the best advisors in the world, you have access to much of the best research and medicine.”

According to Dawn, Harry approached the series openly, showing that he was happy to share his personal experience with viewers.

She told Town & Country magazine, “Harry, he volunteered.

“It was a game to try something out. And we thought well we have the opportunity to film this [therapy] and maybe this is something that will work for some people, maybe not, but the idea is you don’t check the box and you’re done, mental wellbeing is a constant pursuit. “

Dawn admitted that Harry’s transparency made it a lot easier to create the series.

She said, “You have to keep trying new things and pushing yourself forward, and his volunteering to try something was a great way to emphasize and underline that point.”

During the show, Harry admitted that his wife encouraged him to take therapy more seriously.

He shared, “It was a meeting with Meghan. I knew I was going to lose this woman who I could spend the rest of my life with if I didn’t go into therapy and fix myself.”

Sporting clays charity occasion raises cash for service, remedy canines

MIDWAY, Ga. (WSAV) – More than 100 shooters and 20 volunteers attended a sporting event to raise money for service and therapy dogs.

Athletic clay is a type of clay pigeon shooting designed to mimic shooting from living quarries. Attendees also participated in a live auction, two shotgun raffles, and watched working dog demonstrations.

Britnee Kinard, founder and CEO of the nonprofit SD Gunner Fund, said she and her husband saw a “great” need for service animals after her husband was catastrophically injured from military service.

Kinard said around $ 10,000 was raised at the event.

“We started our organization to help members who had service animals, and over the past few years it has grown into training and providing and delivering much more to the community,” Kinard said.

According to Kinard, the non-profit association has had 75 service animals and 5 therapy dogs since it was founded in 2014. Last year, the SD Gunner Fund helped more than 33,000 people, Kinard added.

One of the service dogs named Norbert showed his tricks and training at the event. Norbert is a gluten-alarm allergic dog who is carrying his owner’s medicine and EpiPen.

“Every time our veteran goes out in public, she lets Norbert smell her food or products to see if that product contains gluten,” said Kinard. “If this product contains gluten, he’ll either sit and poke her or poke her to let her know and then she won’t eat this product.”

Kinard said it costs the nonprofit $ 8,000 on average to train their service animals. According to Kinard, the service animals help veterans and autistic children.

The animals are taught how to deal with owners who suffer from PTSD, brain injuries, mobility problems, trauma from sexual assault, anxiety, allergies and much more.